Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Texas Familicare Clinical Research
mi
from
Hurst, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Texas Familicare Clinical Research
mi
from
Hurst, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
DCOL Center for Clinical Research
mi
from
Longview, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
DCOL Center for Clinical Research
mi
from
Longview, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Bexar Clinical Trials, LLC
mi
from
Richardson, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Bexar Clinical Trials, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Advance Research Institute
mi
from
Ogden, UT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Advance Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Highland Clinical Research
mi
from
Salt Lake City, UT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Highland Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
University of Utah
mi
from
Salt Lake City, UT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
New River Valley Research Institute
mi
from
Christianburg, VA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
New River Valley Research Institute
mi
from
Christianburg, VA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Hampton Roads Institute for Performance and Sports Medicine (HIPS)
mi
from
Portsmouth, VA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Hampton Roads Institute for Performance and Sports Medicine (HIPS)
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
McGuire Research Institute
mi
from
Richmond, VA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
McGuire Research Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Northwest Gastroenterology Associates
mi
from
Bellevue, WA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Northwest Gastroenterology Associates
mi
from
Bellevue, WA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Daniel R. Coulston
mi
from
Spokane, WA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Daniel R. Coulston
mi
from
Spokane, WA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  11/2/2015
Hermitage Medicentre
mi
from
Edmonton,
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 11/2/2015
Hermitage Medicentre
mi
from
Edmonton,
Click here to add this to my saved trials
Transcutaneous Electroacupuncture for Gastroparesis
Transcutaneous Electroacupuncture for Gastroparesis
Status: Enrolling
Updated:  11/3/2015
University of Mississippi
mi
from
Jackson, MS
Transcutaneous Electroacupuncture for Gastroparesis
Transcutaneous Electroacupuncture for Gastroparesis
Status: Enrolling
Updated: 11/3/2015
University of Mississippi
mi
from
Jackson, MS
Click here to add this to my saved trials
Transcutaneous Electroacupuncture for Gastroparesis
Transcutaneous Electroacupuncture for Gastroparesis
Status: Enrolling
Updated:  11/3/2015
Texas tech university health science center
mi
from
El Paso, TX
Transcutaneous Electroacupuncture for Gastroparesis
Transcutaneous Electroacupuncture for Gastroparesis
Status: Enrolling
Updated: 11/3/2015
Texas tech university health science center
mi
from
El Paso, TX
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children's Hospital of Orange County
mi
from
Orange, CA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children'S Hospital
mi
from
Aurora, CO
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children's Center for Digestive Healthcare
mi
from
Atlanta, GA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children's Center for Digestive Healthcare
mi
from
Atlanta, GA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Northwestern Scool of Medicine
mi
from
Chicago, IL
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Northwestern Scool of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Center for Children's Digestive Health
mi
from
Park Ridge, IL
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Center for Children's Digestive Health
mi
from
Park Ridge, IL
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Riley Hospital for Children
mi
from
Indianapolis, IN
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Tufts Medical Center
mi
from
Boston, MA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
The Cincinnati Center for Eosinophilic Disorders
mi
from
Cincinnati, OH
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
The Cincinnati Center for Eosinophilic Disorders
mi
from
Cincinnati, OH
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Great Lakes Gastroenterology
mi
from
Mentor, OH
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Rhode Island Hospital
mi
from
Providence, RI
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children's Center for Digestive Health
mi
from
Greenville, SC
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children's Center for Digestive Health
mi
from
Greenville, SC
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
University of Utah Healthcare
mi
from
Salt Lake City, UT
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
University of Utah Healthcare
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Carilion Pediatric Gastroenterology
mi
from
Roanoke, VA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Carilion Pediatric Gastroenterology
mi
from
Roanoke, VA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children's Memorial Hospital
mi
from
Chicago, IL
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
Children's Hospital Boston
mi
from
Boston, MA
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated:  11/3/2015
The Mayo Clinic
mi
from
Rochester, MN
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Status: Enrolling
Updated: 11/3/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Glycerin Suppositories to Reduce Jaundice in Premature Infants
The Use of Glycerin Suppositories to Reduce Hyperbilirubinemia in Premature Infants Requiring Phototherapy
Status: Enrolling
Updated:  11/4/2015
University of Rochester Medical Center NICU
mi
from
Rochester, NY
Glycerin Suppositories to Reduce Jaundice in Premature Infants
The Use of Glycerin Suppositories to Reduce Hyperbilirubinemia in Premature Infants Requiring Phototherapy
Status: Enrolling
Updated: 11/4/2015
University of Rochester Medical Center NICU
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Clinical and Translational Research Institute
mi
from
La Jolla, CA
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Clinical and Translational Research Institute
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Perlman Medical Offices
mi
from
La Jolla, CA
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Perlman Medical Offices
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Thornton Hospital
mi
from
La Jolla, CA
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Thornton Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Community Clinical Trials
mi
from
Orange, CA
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
GastroDiagnostics - Community Clinical Trials Drug
mi
from
Orange, CA
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
GastroDiagnostics - Community Clinical Trials Drug
mi
from
Orange, CA
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Clinical Research of the Rockies
mi
from
LaFayette, CO
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Clinical Research of the Rockies
mi
from
LaFayette, CO
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Medical Research Center of CT Drug
mi
from
Hamden, CT
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Medical Research Center of CT Drug
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated:  11/5/2015
Medical Research Network of Connecticut
mi
from
Hamden, CT
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)
Status: Enrolling
Updated: 11/5/2015
Medical Research Network of Connecticut
mi
from
Hamden, CT
Click here to add this to my saved trials